The additional transplantation of ex vivo generated hematopoietic (post)-progenitor cells represents a possible approach to ameliorate high-dose chemotherapy induced cytopenia. We investigated the feasibility of the large-scale expansion and transplantation of autologous megakaryocytic cells in four patients with advanced solid tumors. Up to 1,460x10(6) ex vivo generated cells were administered without adverse effects but no clear cut effect on platelet recovery was observed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
vivo generated
12
additional transplantation
8
transplantation vivo
8
megakaryocytic cells
8
high-dose chemotherapy
8
generated megakaryocytic
4
cells
4
cells high-dose
4
chemotherapy additional
4
generated hematopoietic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!